Dorton Katina bought PRLD
October 17, 2025 · Form 4 insider transaction
Dorton Katina bought 76,000 shares of Prelude Therapeutics Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
76,000
Price
$0.00
Total value
N/A
InsiderDorton Katina
RoleDirector
SecurityDirector Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 17, 2025
Filing dateOctober 20, 2025
Shares owned after76,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option award vests over a three year period equally one-thirty-sixth per month, subject to Reporting Person's continued service to the Company on each vesting date.